• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

残胃癌的手术治疗

Surgical treatment for advanced carcinoma of the gastric remnant.

作者信息

Isozaki H, Tanaka N, Fujii K, Nomura E, Tanigawa N

机构信息

First Department of Surgery, Okayama University Medical School, Japan.

出版信息

Hepatogastroenterology. 1998 Sep-Oct;45(23):1896-900.

PMID:9840172
Abstract

BACKGROUND/AIMS: Carcinoma of the gastric remnant has increased in recent years, but a therapeutic strategy for this disease has not been established. This retrospective study was performed to determine the most appropriate surgical procedure for carcinoma of the gastric remnant.

METHODOLOGY

A total of 25 patients who underwent operation for advanced carcinoma of the gastric remnant that had developed after distal gastrectomy (13 for benign gastric diseases, B group; 12 for gastric carcinoma, M group) were studied. Clinicopathological features, as well as the status of lymph node metastasis, were investigated in the B and M groups.

RESULTS

There were more patients with carcinoma invading other organs, stage IV disease, and with N2 or more lymph node metastasis (especially, with a high metastatic rate to lymph nodes along the splenic artery) in the M group than in the B group. Forty percent of patients in the M group were treated by left upper abdominal evisceration (LUAE), but only 8% in the B group. The survival rate (5-year, 46.0%) of the B group was significantly higher than that (5-year, 11.9%) of the M group. When we compared the survival rate of carcinoma of the gastric remnant with that of primary carcinoma of the upper third of the stomach, there was no difference between the two groups in the curative resection cases.

CONCLUSIONS

Almost the same surgical strategy can be adopted for the B group as for primary gastric carcinoma. On the other hand, for the M group, a radical surgical procedure, LUAE, should be recommended.

摘要

背景/目的:近年来,残胃癌的发病率有所上升,但针对该疾病的治疗策略尚未确立。本回顾性研究旨在确定残胃癌最合适的手术方式。

方法

对25例行手术治疗的残胃癌患者进行研究,这些患者均为远端胃切除术后发生的进展期残胃癌(良性胃病患者13例,B组;胃癌患者12例,M组)。对B组和M组的临床病理特征以及淋巴结转移情况进行了调查。

结果

M组中侵犯其他器官、处于IV期、伴有N2及以上淋巴结转移(尤其是脾动脉旁淋巴结转移率高)的患者比B组更多。M组40%的患者接受了左上腹脏器清除术(LUAE),而B组仅为8%。B组的生存率(5年生存率为46.0%)显著高于M组(5年生存率为11.9%)。当我们比较残胃癌与胃上部三分之一原发性癌的生存率时,两组在根治性切除病例中无差异。

结论

B组可采用与原发性胃癌几乎相同的手术策略。另一方面,对于M组,应推荐行根治性手术,即LUAE。

相似文献

1
Surgical treatment for advanced carcinoma of the gastric remnant.残胃癌的手术治疗
Hepatogastroenterology. 1998 Sep-Oct;45(23):1896-900.
2
Results of curative gastrectomy for carcinoma of the distal third of the stomach.胃远端三分之一癌根治性胃切除术的结果
J Am Coll Surg. 1996 Sep;183(3):201-7.
3
Lymph node dissection in surgical treatment for remnant stomach cancer.残胃癌手术治疗中的淋巴结清扫术。
Hepatogastroenterology. 2002 Mar-Apr;49(44):580-4.
4
[Analyses of surgical treatment and prognosis in gastric stump cancer].[胃残端癌的外科治疗与预后分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Jan;12(1):28-31.
5
A new surgical technique (left upper abdominal evisceration) for advanced carcinoma of the gastric stump.
Hepatogastroenterology. 1994 Apr;41(2):130-3.
6
Progression and prognosis of gastric stump cancer.残胃癌的进展与预后
J Surg Oncol. 2009 Nov 1;100(6):472-6. doi: 10.1002/jso.21370.
7
Role of surgery in the patients with stage I and II primary gastric lymphoma.手术在Ⅰ期和Ⅱ期原发性胃淋巴瘤患者中的作用。
Hepatogastroenterology. 2003 May-Jun;50(51):877-82.
8
Early gastric cancer in the remnant stomach.残胃早期胃癌
Hepatogastroenterology. 1998 Sep-Oct;45(23):1907-11.
9
Indications for pancreaticosplenectomy in advanced gastric cancer.进展期胃癌行胰脾切除术的适应证
Hepatogastroenterology. 2001 May-Jun;48(39):908-12.
10
Gastrectomy with combined resection of other organs for carcinoma of the stomach with invasion to adjacent organs: clinical efficacy in a retrospective study.胃癌侵犯相邻器官时行胃切除术联合其他器官切除术:一项回顾性研究的临床疗效
J Am Coll Surg. 1997 Jan;184(1):16-22.

引用本文的文献

1
[Gastric stump carcinoma: frequency, treatment, complications and prognosis].[残胃癌:发病率、治疗、并发症及预后]
Chirurg. 2017 Apr;88(4):317-327. doi: 10.1007/s00104-016-0296-9.
2
Does remnant gastric cancer really differ from primary gastric cancer? A systematic review of the literature by the Task Force of Japanese Gastric Cancer Association.残胃癌真的与原发性胃癌不同吗?日本胃癌协会特别工作组对文献的系统评价
Gastric Cancer. 2016 Apr;19(2):339-349. doi: 10.1007/s10120-015-0582-0. Epub 2015 Dec 14.
3
Clinicopathologic features of remnant gastric cancer over time following distal gastrectomy.
远端胃切除术后残胃癌随时间变化的临床病理特征
World J Gastroenterol. 2015 May 21;21(19):5972-8. doi: 10.3748/wjg.v21.i19.5972.
4
The early diagnosis and surgical treatment of the gastric stump carcinoma.
J Tongji Med Univ. 2000;20(4):315-7. doi: 10.1007/BF02888189.